Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) EBIT Margin: 2009-2025

Historic EBIT Margin for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -13.38%.

  • Lifecore Biomedical's EBIT Margin rose 894.00% to 14.62% in Q2 2025 from the same period last year, while for May 2025 it was -13.38%, marking a year-over-year decrease of 649.00%. This contributed to the annual value of -13.38% for FY2025, which is 649.00% down from last year.
  • Per Lifecore Biomedical's latest filing, its EBIT Margin stood at -13.38% for FY2025, which was down 94.07% from -6.90% recorded in FY2024.
  • Over the past 5 years, Lifecore Biomedical's EBIT Margin peaked at -6.90% during FY2024, and registered a low of -21.11% during FY2023.
  • Over the past 3 years, Lifecore Biomedical's median EBIT Margin value was -13.38% (recorded in 2025), while the average stood at -13.79%.
  • As far as peak fluctuations go, Lifecore Biomedical's EBIT Margin plummeted by 1,051bps in 2023, and later spiked by 1,421bps in 2024.
  • Yearly analysis of 5 years shows Lifecore Biomedical's EBIT Margin stood at -8.75% in 2021, then plummeted by 185bps to -10.60% in 2022, then tumbled by 1,051bps to -21.11% in 2023, then surged by 1,421bps to -6.90% in 2024, then slumped by 649bps to -13.38% in 2025.